Corporate Profile

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease.

The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.

The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital ... More >>

Stock Quote

CSII (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Down 0.11 (0.38%)
Data as of 08/29/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Recent News

More >>
Cardiovascular Systems Reports Fiscal 2014 Fourth-Quarter and Full-Year Financial Results
Conference Call Scheduled for Today, August 6, 2014, at 3:45 PM CT (4:45 PM ET) Key Financial and Operating Highlights for the Fourth Quarter: Revenues of $39.6 million rose 37 percent from 2013 fourth quarter Market expanding Diamondback 360® Coronary and Diamondback 360® 60cm Peripheral Orbital Atherectomy Systems (OAS) contribute to strong top-line growth Company enrolls first pa... 
Cardiovascular Systems to Webcast Fiscal 2014 Fourth-Quarter Earnings Conference Call Wednesday, August 6
Live Webcast at 3:45 p.m. CT (4:45 p.m. ET) ST. PAUL, Minn.--(BUSINESS WIRE)--Jul. 23, 2014-- Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2014 fourth-quarter conference call on Wednesday, August 6, 2014, at 3:45 p.m. CT (4:45 p.m. ET). David Martin, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss the company’s results for its fiscal fourth quarter end... 
Cardiovascular Systems Announces Plans for New Corporate Headquarters
Facility to Accommodate Anticipated Growth Company Will Remain in New Brighton, Minn. ST. PAUL, Minn.--(BUSINESS WIRE)--Jun. 12, 2014-- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced plans to build a new corporate headquarters in New Brighton, Minn. The 125,000-square-foot, two-story building will have space for more than 500 employees and contain dedicated research and development, training and ed... 
Cardiovascular Systems Enrolls First Patient in Coast Study
International Coronary Trial Taking Place in United States and Japan Study to Assess Safety and Efficacy of New Coronary Micro Crown ST. PAUL, Minn.--(BUSINESS WIRE)--Jun. 11, 2014-- Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), announced that the first patient has been enrolled in its Coronary Orbital Atherectomy System Trial (COAST) trial. Taking place in the United States and Japan, the study is designed to assess the... 

Upcoming Events

More >>
There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.